TEM Rentabilitas dodolan miturut bathi resik Tempus

TEM (Tempus AI Inc) - tandha merek perusahaan

Tempus AI, Inc (TEM) is capturing the personalized treatment segment by leveraging AI to analyze DNA and sell unique analytics to pharmaceutical giants. Net profit margin reflects a turning point driven by the implementation of the oncology platform in clinics and the scaling of subscriptions. Growth is fueled by contracts with Big Pharma, which create a stable cash flow. The value of -12.50 represents the current figure for this metric.

Tempus AI, Inc (TEM) - Margin resik saka 15.06.2024 nganti 19.11.2026

Rincian metrik komprehensif lan analitis Tempus AI Inc (TEM)

- rega saham lan prakiraan rega para ahli:
Ringkesan analisis perusahaan:Tempus AI, Inc - TEM
Barang unggulan Tempus AI, Inc.

Investors utilize this indicator as a barometer of operational efficiency and the issuer's ability to generate profit from every dollar of revenue. The ratio of net income to total sales, reflected through the net profit margin, confirms the ability of Tempus AI, Inc (TEM) management to monetize genomic data sets and integrate AI solutions into diagnostics, transforming technological potential into real financial stability.

Analisis pesaing

qiagen.com (QGEN) - Margin resik|Ionis (IONS) - Margin dodolan resik|Margin resik Repligen|Avidity (RNA) - Margin dodolan perusahaan|Margin dodolan resik CRSP|Margin dodolan perusahaan GeneDx|Margin resik Ultragenyx RARE|Margin dodolan perusahaan Beam Therapeutics (BEAM)|SRPT: Rentabilitas dodolan miturut bathi resik|Margin resik Twist Bioscience|TXG (10x Genomics) - Rentabilitas dodolan miturut bathi resik|Intellia Therapeutics, Inc. (NTLA) - Margin dodolan resik|Margin resik Stoke Therapeutics Inc|BLFS: Tingkat bathi resik|Rentabilitas dodolan miturut bathi resik WVE (Wave Life Sciences Corp)|Margin dodolan perusahaan Maze Therapeutics Corp|Sionna Therapeutics Inc - Rentabilitas dodolan miturut bathi resik|PRME (primemedicine.com) - Margin bathi resik|TSHA - Margin resik|QURE (uniQure) - Rentabilitas dodolan resik|MeiraGTx Corp (MGTX) - Margin resik|Regenxbio - Tingkat bathi resik|Margin resik solidbio.com|Margin resik ocugen.com OCGN|Margin dodolan resik PACB|Benitec - Rentabilitas dodolan resik|Margin resik Design Therapeutics DSGN|Margin dodolan resik Rocket Pharmaceuticals RCKT|Margin bathi resik 4D Molecular Corp|LXEO: Margin resik|KRRO (Korro Bio, Inc) - Rentabilitas dodolan miturut bathi resik|Editas Medicine (EDIT) - Margin dodolan resik|Margin resik Silence Therapeutics Inc.|Rentabilitas dodolan resik PRQR (proqr.com)|Margin resik Codexis Bio (CDXS)|Margin dodolan resik sangamo.com (SGMO)|Margin resik nautilus.bio NAUT|Margin dodolan perusahaan Metagenomi, Inc (MGX)|Precision BioSciences Inc. - Margin dodolan resik|GBIO - Margin dodolan resik|BOLD: Margin dodolan resik|Rentabilitas dodolan resik XCUR|Margin resik Imunon|Phio Pharmaceuticals - Margin bathi resik|Margin resik Mustang Bio, Inc. (MBIO)|Margin dodolan perusahaan TransCode Therapeutics, Inc.|Margin resik Bionano Genomics BNGO|Tingkat bathi resik APDN|BLUE - Margin resik|Margin bathi resik IPA|Omega Therapeutics, Inc. (OMGA) - Margin resik|Singular Genomics Corp (OMIC) - Margin dodolan resik|RGLS (Regulus Therapeutics, Inc.) - Margin dodolan resik|SYRS: Tingkat bathi resik|Rentabilitas dodolan miturut bathi resik TBIO (Telesis Bio Inc.)|Margin dodolan resik TRACON Pharmaceuticals Inc. (TCON)|Margin resik Unity Bio UBX